Genentech Q&A: Improving MS treatment and clinical trial diversity
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population […]
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »











